“A bill to withdraw normal trade relations treatment with respect to the People's Republic of China, and for other purposes.”
No CRS summary available for this bill.
This section states congressional findings on the People's Republic of China's (PRC) trade practices and their impacts on the United States, including (1) PRC's violations of commitments made upon receiving permanent normal trade relations (PNTR) status in 2000 and acceding to the World Trade Organization in 2001, (2) $130 billion in U.S. tariff evasion costs in 2023, annual intellectual property theft of $180-$540 billion, and $407 billion in de facto subsidies in 2019; (3) failure to meet Phase One trade deal purchase commitments by 60% for goods; (4) U.S. loss of 5 million manufacturing jobs and 90,000 factories from 1994 through April 2025, with U.S. world manufacturing share declining from 28% in 2001 to 17% in 2024; and (5) PRC threats to global rare earths supply justifying invocation of GATT 1994 Article XXI—mirroring the World Trade Organization's 2022 action against Russia—to revoke PRC's PNTR status on essential security grounds.
This section withdraws normal trade relations (NTR) treatment—i.e., column 1 tariff rates of the Harmonized Tariff Schedule of the United States—from products of the People's Republic of China (PRC), including those from the governments of Hong Kong and Macau special administrative regions and their agencies or instrumentalities, effective 90 days after enactment. It (1) terminates NTR pursuant to section 101 of Public Law 106-286; (2) prohibits future NTR extension under chapter 1 of title IV of the Trade Act of 1974 (19 U.S.C. 2431 et seq.); (3) applies column 2 (non-NTR) tariff rates to all such products; and (4) authorizes the President to proclaim higher rates than column 2. (Thus, nearly all U.S. imports from the PRC will face substantially higher duties.)